CHANGE: HAVE WE PASSED PEAK OBESITY?
We already know from clinical trials that Ozempic and other GLP-1 drugs produce sustained reductions in body weight, but with mass public usage taking off — one in eight US adults have used the drugs — the results may now be showing up at population level. pic.twitter.com/e1FxDkBh3X
— John Burn-Murdoch (@jburnmurdoch) October 4, 2024